Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2015, Article ID 192736, 8 pages
http://dx.doi.org/10.1155/2015/192736
Research Article

Anti-Thyroid Peroxidase Antibody in Vitiligo: A Prevalence Study

1Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College and Dr. Prabhakar Kore KLES Hospital, Belgaum, Karnataka 590010, India
2The INCLEN Trust International, New Delhi 110020, India

Received 27 September 2014; Revised 20 December 2014; Accepted 21 December 2014

Academic Editor: Fausto Bogazzi

Copyright © 2015 R. Dash et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. B. Mosher, T. B. Fitzpatrick, J. P. Ortonne et al., “Disorders of melanocytes,” in Dermotology in General Medicine, T. B. Fizpatrick, A. Z. Eisen, K. Wolff, and etal, Eds., pp. 945–1017, McGraw-Hill, New York, NY, USA, 5th edition, 1999. View at Google Scholar
  2. R. M. Halder and S. J. Taliaferro, “Vitiligo,” in Fitzpatrick's Dermatology in General Medicine, L. A. Goldsmith, S. I. Katz, B. A. Gichrest, A. S. Paller, and D. J. Leffell, Eds., p. 616, McGraw-Hill, New York, NY, USA, 7th edition, 2008. View at Google Scholar
  3. S. K. Hann and J. J. Nordund, “Clinical features of generalized vitiligo,” in A Monograph on the Basic and Clinical Science, S. K. Hann and J. J. Nordlund, Eds., pp. 35–48, Blackwell Science, 2000. View at Google Scholar
  4. J. C. Bystryn, “Theories in the pathogenesis of depigmentation: immune hypothesis,” in Vitiligo: A Monograph on the Basic and Clinical Science, S. K. Hann and J. Jeds, Eds., pp. 129–136, Blackwell Science, 2000. View at Google Scholar
  5. W. J. Cunliffe, R. Hall, D. J. Newell, and C. J. Stevenson, “Vitiligo, thyroid disease and autoimmunity.,” British Journal of Dermatology, vol. 80, no. 3, pp. 135–139, 1968. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Brostoff, S. Bor, and M. Feiwel, “Autoantibodies in patient with vitiligo,” The Lancet, vol. 2, p. 177, 1969. View at Google Scholar
  7. C. Betterle, G. F. del Prete, A. Peserico et al., “Autoantibodies in vitiligo,” Archives of Dermatology, vol. 112, no. 9, article 1328, 1976. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Vrijman, M. W. Kroon, J. Limpens et al., “The prevalence of thyroid disease in patients with vitiligo: a systematic review,” British Journal of Dermatology, vol. 167, no. 6, pp. 1224–1235, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Dave, M. D'souza, D. M. Thappa, K. S. Reddy, and Z. Bobby, “High frequency of thyroid dysfunction in Indian patients with vitiligo,” Indian Journal of Dermatology, vol. 48, pp. 68–72, 2003. View at Google Scholar
  10. C. Betterle, A. Caretto, A. de Zio et al., “Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo,” Dermatologica, vol. 171, no. 6, pp. 419–423, 1985. View at Publisher · View at Google Scholar · View at Scopus
  11. K. U. Schallreuter, R. Lemke, O. Brandt et al., “Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients,” Dermatology, vol. 188, no. 4, pp. 269–275, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Hegedus, M. Heidenheim, M. Gervil, H. Hjalgrim, and M. Hoier-Madsen, “High frequency of thyroid dysfunction in patients with vitiligo,” Acta Dermato-Venereologica, vol. 74, no. 2, pp. 120–123, 1994. View at Google Scholar · View at Scopus
  13. R. C. Mandry, L. J. Ortíz, A. Lugo-Somolinos, and J. L. Sánchez, “Organ-specific autoantibodies in vitiligo patients and their relatives,” International Journal of Dermatology, vol. 35, no. 1, pp. 18–21, 1996. View at Google Scholar · View at Scopus
  14. M. Daneshpazhooh, G. M. Mostofizadeh, J. Behjati, M. Akhyani, and R. M. Robati, “Anti-thyroid peroxidase antibody and vitiligo: a controlled study,” BMC Dermatology, vol. 6, article 3, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. H. Altaf, I. H. Shah, and Q. M. Ahmad, “Evaluation of thyroid function and presence of antithyroid peroxidise antibodies in patients with vitiligo,” Egyptian Dermatology Online Journal, vol. 6, no. 1, p. 3, 2010. View at Google Scholar
  16. J. J. Nordlund and P. P. Majumder, “Recent investigations on vitiligo vulgaris,” Dermatologic Clinics, vol. 15, no. 1, pp. 69–78, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. R. P. R. Dawber, “Clinical associations of vitiligo,” Postgraduate Medical Journal, vol. 46, no. 535, pp. 276–277, 1970. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Bor, M. Feiwel, and I. Chanarin, “Vitiligo and its aetiological relationship to organ-specific autoimmune disease,” British Journal of Dermatology, vol. 81, no. 2, pp. 81–83, 1969. View at Publisher · View at Google Scholar · View at Scopus
  19. P. P. Majumder, J. J. Nordlund, and S. K. Nath, “Pattern of familial aggregation of vitiligo,” Archives of Dermatology, vol. 129, no. 8, pp. 994–998, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Arýcan, K. Koç, and L. Ersoy, “Clinical characteristics in 113 Turkish vitiligo patients,” Acta Dermatovenerologica Alpina, Panonica, et Adriatica, vol. 17, no. 3, pp. 129–132, 2008. View at Google Scholar
  21. S. Dogra, D. Parsad, S. Handa, and A. J. Kanwar, “Late onset vitiligo: a study of 182 patients,” International Journal of Dermatology, vol. 44, no. 3, pp. 193–196, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. J. Howitz, H. Brodthagen, M. Schwartz, and K. Thomsen, “Prevalence of vitiligo,” Archives of Dermatology, vol. 113, no. 1, pp. 47–52, 1977. View at Publisher · View at Google Scholar · View at Scopus
  23. M. S. Song, S. K. Hann, P. S. Ahn et al., “Clinical study of vitiligo: comparative study of type A and type B vitiligo,” Annals of Dermatology, vol. 6, pp. 22–30, 1994. View at Google Scholar
  24. S.-K. Hann, W. H. Chun, and Y.-K. Park, “Clinical characteristics of progressive vitiligo,” International Journal of Dermatology, vol. 36, no. 5, pp. 353–355, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Bhor and S. Pande, “Scoring systems in dermatology,” Indian Journal of Dermatology, Venereology and Leprology, vol. 72, no. 4, pp. 315–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. El Mofty and M. El Mofty, “Vitiligo. A sympton complex,” International Journal of Dermatology, vol. 19, no. 5, pp. 237–244, 1980. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Handa and I. Kaur, “Vitiligo: clinical findings in 1436 patients,” Journal of Dermatology, vol. 26, no. 10, pp. 653–657, 1999. View at Google Scholar · View at Scopus
  28. D. H. Nunes and L. M. H. Esser, “Vitiligo epidemiological profile and the association with thyroid disease,” Anais Brasileiros de Dermatologia, vol. 86, no. 2, pp. 241–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Al-Mutairi and A. K. Sharma, “Profile of vitiligo in Farwaniya region in Kuwait,” Kuwait Medical Journal, vol. 38, no. 2, pp. 128–131, 2006. View at Google Scholar
  30. M. I. Barona, A. Arrunategui, R. Falabella, and A. Alzate, “An epidemiologic case-control study in a population with vitiligo,” Journal of the American Academy of Dermatology, vol. 33, no. 4, pp. 621–625, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. P. N. Behl and R. K. Bhatia, “400 cases of vitiligo. A clinico-therapeutic analysis,” Indian Journal of Dermatology, vol. 17, no. 2, pp. 51–56, 1972. View at Google Scholar · View at Scopus
  32. M. Koga and T. Tango, “Clinical features and course of type A and type B vitiligo,” British Journal of Dermatology, vol. 118, no. 2, pp. 223–228, 1988. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Cho, J. H. Kim, J. M. Park, Y. K. Park, and S. H. Oh, “Vitiligo in children and adolescents: association with thyroid dysfunction,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 1, pp. 64–67, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. K. Ezzedine, A. Diallo, C. Léauté-Labrèze et al., “Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo,” British Journal of Dermatology, vol. 166, no. 3, pp. 539–544, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. A. Imam, M. Abdallah, and H. M. Ema, “Estimation of antithyroid microsomal antibodies in Egyptian vitiligo patients of different age groups,” Journal of the Arab Society for Medical Research, vol. 2, no. 2, pp. 135–142, 2007. View at Google Scholar
  36. E. H. Kemp, “Autoantibodies as diagnostic and predictive markers of vitiligo,” Autoimmunity, vol. 37, no. 4, pp. 287–290, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. R. A. Nordyke, F. I. Gilbert Jr., L. A. Miyamoto, and K. A. Fleury, “The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis,” Archives of Internal Medicine, vol. 153, no. 7, pp. 862–865, 1993. View at Publisher · View at Google Scholar · View at Scopus